Patrick L. McCrory Elected to Kewaunee Scientific Board of Directors

STATESVILLE, N.C., May 27 -- Kewaunee Scientific Corporation (Nasdaq: KEQU - News) announced today the election of Patrick L. McCrory to Kewaunee Scientific's Board of Directors. Mr. McCrory, a resident of Charlotte, North Carolina, is a partner with McCrory & Company, a business consulting firm, and is also serving his seventh and final term as [...]

SRU Biosystems Expands Sales Team and Appoints New Director of Cell Biology

WOBURN, Mass.--SRU Biosystems, a leader in label-free technologies, today announced that the Company has expanded its sales team with the addition of Senior Sales Executives Jane Clark and Rick Loomis to its North American division. Further, the Company announced the appointment of Steve Shamah, Ph.D., as its new Director of Cell Biology and member of [...]

Hamilton Robotics Automates the Promega CellTiter-Glo* Cell Viability Assay for High-Throughput Applications

Reno, Nevada (May 27, 2009) - Hamilton Robotics announced today a successful collaboration with Madison, Wisconsin-based Promega Corporation to automate the CellTiter-Glo luminescent cell viability assay on Hamilton's MICROLAB® STAR liquid handling workstation. The two companies have developed an automated, tested and verified protocol for the fast and accurate dispensing of the Promega reagent in [...]

UU Framework uses new HACH LANGE sensors

United Utilities has extended its Framework Agreement with HACH LANGEand added two new sensors; the LDO™ (Luminescent Dissolved Oxygen) sensor and the NH4D ammonium sensor. United Utilities and HACH LANGE have extended a Framework Agreement originally signed in May 2006 and added two new sensors; the LDO™ (Luminescent Dissolved Oxygen) sensor and the NH4D ammonium [...]

HORIBA Introduces New Division and Team

Chemistry and haematology bench top analysis anywhere PRLog (Press Release) – May 27, 2009 – Northampton, UK: Renowned specialists in the design and manufacture of systems and instruments for analysing and measuring gases, liquids and solids, the HORIBA Group introduces its newest division - HORIBA Medical which specialises in automated in vitro diagnostics. Although the [...]

Gene Network Sciences Announces Broad Cancer Collaboration With UCSF and Initial Results

CAMBRIDGE, Mass., May 27 -- Gene Network Sciences, Inc. (GNS) today announced that it has entered into a research collaboration with the University of California San Francisco Cancer Center (UCSF) aimed at accelerating cancer research and drug development across several therapeutic areas. This collaboration will combine the clinical and research oncology expertise of UCSF with [...]

ForteBio Launches New Assay Capabilities

ForteBio Launches New Assay Capabilities for High-Sensitivity Protein Quantitation and Fragment Screening on its Octet® Platform MENLO PARK, Calif. — ForteBio®, Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced that it has launched two new assay modules – for high-sensitivity protein quantitation and fragment screening, [...]

Proteome Sciences plc (‘Proteome Sciences’) License Agreement in Brain Damage

27th May, 2009 Proteome Sciences plc has entered into a license agreement with Axela Inc. for the development of assays to measure its proprietary brain damage biomarkers on Axela's multiplex biomarker assay dotLab™ System. Proteome Sciences has established a strong portfolio of patent protected blood biomarkers of brain damage-related disorders working in collaboration with the [...]

Dual block cycling for under Euros 5k

G-Storm GS482 meets growing need for “personal” instruments Braintree, UK, May 27, 2009: Gene Technologies Ltd, the UK-based life sciences instrumentation manufacturer today announced the launch of the GS-482, the latest thermal cycler in the highly successful G-Storm range. In the current difficult climate, the GS 482 thermal cycler is an ideal solution for scientists [...]

QIAGEN to Supply Molecular Screening Solutions to Increase Safety of Blood Donations in Brazil Agreement Covers Reagents and Instruments for Testing Samples For HIV and HCV

VENLO, Netherlands--QIAGEN (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that it has entered into an agreement to supply molecular sample and assay technologies for a new national, PCR-based blood screening program for HIV and Hepatitis C (HCV) in Brazil. QIAGEN will provide Bio-Manguinhos, the main provider of vaccines and diagnostics to the Brazilian Ministry [...]

Access IBO on Knowledge Center